That's a wrap.
Market opens Friday, Nov 13 at 9:30 AM ET
10:11 PMYahoo Finance
Is Arrowhead Pharmaceuticals (ARWR) worth its price after UK approval?
4:00 PMYahoo Finance
Arrowhead Pharmaceuticals to participate in upcoming investor Conferences
4:15 PMYahoo Finance
Arrowhead Pharmaceuticals Presents Plozasiran data highlighting Sustained Triglyceride Reductions and Reduced Acute Pancreatitis rates
7:30 AMYahoo Finance
Arrowhead Pharmaceuticals Refinances Existing Credit Facility, lowering borrowing costs and Extending Maturity
Arrowhead Pharmaceuticals to Webcast 2026 fiscal year-end results
Arrowhead Pharmaceuticals to present important Clinical data at the American Heart Association Scientific sessions 2026
11:36 AMYahoo Finance
Adults living with Familial Chylomicronaemia Syndrome (FCS) in England and Wales have REDEMPLO® (Plozasiran) as a new treatment option to Reduce Triglycerides